These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4582438)

  • 21. Pulmonary disease due to Mycobacterium intracellulare.
    Yeager H; Raleigh JW
    Am Rev Respir Dis; 1973 Sep; 108(3):547-52. PubMed ID: 4745250
    [No Abstract]   [Full Text] [Related]  

  • 22. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 23. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
    Nitti V; Catena E; Delli Veneri F; De Michele G; Marra A
    Am Rev Respir Dis; 1971 Mar; 103(3):329-37. PubMed ID: 5005040
    [No Abstract]   [Full Text] [Related]  

  • 24. Some clinical aspects and treatment of anonymous mycobacterial infections.
    Davey ME
    Med J Aust; 1967 Sep; 2(10):438-41. PubMed ID: 4168734
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis.
    Ogawa T; Motomura K
    Kekkaku; 1971 Sep; 46(9):365-70. PubMed ID: 5122006
    [No Abstract]   [Full Text] [Related]  

  • 26. [Synergistic effects of davercin, rifampicin, ethambutol and isonicotinic acid hydrazide on selected standard strains of Mycobacterium in the in-vitro and in-vivo experiments].
    Janowiec M; Andrzejczyk Z; Szwedowicz I
    Pneumonol Pol; 1988 Jun; 56(6):278-82. PubMed ID: 3226945
    [No Abstract]   [Full Text] [Related]  

  • 27. The relationship between the in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment.
    Heginbothom ML
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):539-45. PubMed ID: 11409581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on atypical mycobacteria. IX. Chemotherapy gainst exprimentally atypical mycobacteriosis of mice--experiments on Morita strain infection in mice.
    Ogawa T; Hiraki M
    Kitasato Arch Exp Med; 1969 Dec; 42(3):83-90. PubMed ID: 5400761
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on discharge of atypical myocbacteria in ambulatory patients and treatment of pulmonary disease caused by atypical mycobacteria (so-called atypical mycobacteriosis)].
    Yamaguchi T; Toyohara M
    Kekkaku; 1967 Jul; 42(7):245-50. PubMed ID: 5583607
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic results in lung diseases caused by atypical mycobacteria].
    Fischer P; Schilling W
    Z Erkr Atmungsorgane; 1984; 162(1):26-9. PubMed ID: 6202070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disseminated Mycobacterium kansasii infection: successful treatment of a patient with pancytopenia.
    Engstrom PF; Dewey GC; Barrett ON
    Am J Med; 1972 Apr; 52(4):533-7. PubMed ID: 5017246
    [No Abstract]   [Full Text] [Related]  

  • 32. Genitourinary infection due to Mycobacterium kansasii.
    Hepper NG; Karlson AG; Leary FJ; Soule EH
    Mayo Clin Proc; 1971 Jun; 46(6):387-90. PubMed ID: 5088980
    [No Abstract]   [Full Text] [Related]  

  • 33. Surgical treatment in pulmonary infections due to atypical mycobacterium.
    Polk JW; Ponce L; Medina M
    Am J Surg; 1967 Nov; 114(5):739-43. PubMed ID: 5603331
    [No Abstract]   [Full Text] [Related]  

  • 34. The course of untreated Mycobacterium kansasii disease.
    Francis PB; Jay SJ; Johanson WG
    Am Rev Respir Dis; 1975 Apr; 111(4):477-87. PubMed ID: 1124888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The radish bacillus (Mycobacterium terrae): saphrophyte or pathogen?
    Cianciulli FD
    Am Rev Respir Dis; 1974 Jan; 109(1):138-41. PubMed ID: 4588088
    [No Abstract]   [Full Text] [Related]  

  • 36. Environmental mycobacteria. An increasing problem.
    Griffith DE
    Hosp Pract (Off Ed); 1988 May; 23(5):125-30, 132, 137 passim. PubMed ID: 3131352
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experimental study of 2d order tuberculostatic preparations in Mycobacterium bovis resistance to isoniazid or streptomycin (based on the data from a morphological study)].
    Golyshevskaia VI; El'shanskaia MP
    Farmakol Toksikol; 1975; 38(2):222-4. PubMed ID: 776650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.
    Newman R; Doster BE; Murray FJ; Woolpert SF
    Am Rev Respir Dis; 1974 Feb; 109(2):216-32. PubMed ID: 4204541
    [No Abstract]   [Full Text] [Related]  

  • 39. Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria.
    Hoffner SE
    Eur J Clin Microbiol Infect Dis; 1994 Nov; 13(11):937-41. PubMed ID: 7698120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.